Knockdown SNHG4 may inhibit the growth of tumours including renal cell carcinoma (RCC) [31], colorectal cancer (CRC) [27], cervical cancer (CC) [28], lung cancer [32], and non-small cell lung cancer (NSCLC) [29]. Here, SNHG4 is linked to non-small cell lung carcinoma.